The Impact of education on adherence to treatment in HIV-positive patients

The effect of education based on health promotion model on adherence to treatment in HIV-positive patients in Bushehr

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015022821262N1

Enrollment

Registered

2015-08-04

Start date

2015-04-16

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV. Human immunodeficiency virus [HIV] disease

Interventions

Intervention 1: The intervention group, will be provided face to face training for 30 patients treated during two sessions spaced two weeks, and the booklet in the first session and drug boxes to red

The intervention group, will be provided face to face training for 30 patients treated during two sessions spaced two weeks, and the booklet in the first session and drug boxes to reduce the forgotte

Control group during the study period to will receive care routine center.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age over 18 years; The indications for Antiretroviral therapy; literacy; Mental health. Exclusion criteria: No willingness to participation in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Perceived Benefits. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: 5 questions chosen from the astandard questionnaire attitude to drug.;Perceived Barriers. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: Barriers to Medication Adherence Questionnaire (PMAQ).;Perceived Self-Efficacy. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: Adherence Self-Efficacy Questionnaire.;Social Protection. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: Social Support Questionnaire Shrburn and Stewart.;Feelings Related to Behavior. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: Believe about Medication Questionnaires (BMQ).;Adherence to Medication. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: Self-Report.	—

Measure

Time frame

Perceived Benefits. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: 5 questions chosen from the astandard questionnaire attitude to drug.;Perceived Barriers. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: Barriers to Medication Adherence Questionnaire (PMAQ).;Perceived Self-Efficacy. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: Adherence Self-Efficacy Questionnaire.;Social Protection. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: Social Support Questionnaire Shrburn and Stewart.;Feelings Related to Behavior. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: Believe about Medication Questionnaires (BMQ).;Adherence to Medication. Timepoint: Before the intervention, two weeks after the beginning of the study, three months after the intervention. Method of measurement: Self-Report.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Azita Noroozi

Bushehr University of Medical Sciences

azitanoroozi@yahoo.com+98 77 3455 0089

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026